Phytonadione NDC 69238-1051

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1051Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1051Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1051-1	69238105101	1 BOTTLE in 1 CARTON (69238-1051-1) / 100 TABLET in 1 BOTTLEMarketed from May 15, 2018
69238-1051-3	69238105103	1 BOTTLE in 1 CARTON (69238-1051-3) / 30 TABLET in 1 BOTTLEMarketed from May 15, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phytonadione
Generic name (nonproprietary): phytonadione
Active ingredients: Phytonadione — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209373
Marketing start: May 15, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Increased Prothrombin Activity (Physiologic effect)Reversed Anticoagulation Activity (Physiologic effect)Vitamin K (Chemical structure)
Identifiers: Product ID 69238-1051_94d89db9-981d-4fc5-b6fe-5d4b73230e35SPL ID 94d89db9-981d-4fc5-b6fe-5d4b73230e35SPL set ID 54c1c1df-0e65-4da8-9023-6cbaa0f5bd0dRxCUI 198102UNII A034SE7857
Pharmacologic class: Vitamin K; Warfarin Reversal Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238105101 followed by a unit qualifier and the quantity

Package 69238-1051-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 9, 2024.

Indications (excerpt from the label)

Phytonadione tablets are indicated for the treatment of adults with the following coagulation disorders which are due to faulty formation of factors II, VII, IX and X when caused by vitamin K deficiency or interference with vitamin K activity. Anticoagulant-induced hypoprothrombinemia caused by coumarin or indanedione derivatives. Hypoprothrombinemia secondary to antibacterial therapy. Hypoprothrombinemia secondary to factors limiting absorpsion or synthesis of vitamin K, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancrease, and regional enteritis. Other drug-induced hypoprothrombinemia where it is defi…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209373

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209373
Product	Strength	Form · route	Labeler	Product NDC
Phytonadione	Phytonadione 5 mg/1	TabletOral	Major Pharmaceuticals	0904-6882
Phytonadione	Phytonadione 5 mg/1	TabletOral	American Health Packaging	60687-381